We found tGLI1, GP130, and pSTAT3-Y705 to be frequently co-expressed in HER2-enriched breast cancer and TNBC cell lines, which are considered as the more aggressive subtypes of breast cancer (Figure 1A). This evidence concerns the gene ERBB2 and breast carcinoma.